Benefit from atezolizumab in patients with a poor prognostic ovarian cancer in first-line setting: IMAGYN-050 trial Meeting Abstract
| Authors: | You, B.; Anderson, C.; Cecere, S. C.; Carrot, A.; Myers, T.; Heitz, F.; Sudarshan, S.; Selcukbiricik, F.; Aghajanian, C.; Fernebro, J.; Blank, S.; Laudani, M. E.; Thaker, P.; Yunokawa, M.; Willmott, L.; He, Y.; Landen, C.; Lin, Y. G.; AlarcoĢn, J.; Moore, K. N. |
| Abstract Title: | Benefit from atezolizumab in patients with a poor prognostic ovarian cancer in first-line setting: IMAGYN-050 trial |
| Meeting Title: | 2024 International Meeting of the European Society of Gynaecological Oncology (ESGO) |
| Journal Title: | International Journal of Gynecological Cancer |
| Volume: | 34 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2024 Mar 7-10 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 1048-891X |
| Publisher: | Lippincott Williams & Wilkins |
| Date Published: | 2024-03-01 |
| Start Page: | A37 |
| Language: | English |
| ACCESSION: | WOS:001443888200042 |
| DOI: | 10.1136/ijgc-2024-ESGO.46 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 562 -- Source: Wos |
